Michael P. Phalen, EVP & President, Med Surg at BOSTON SCIENTIFIC CORP (BSX), sold 46,085 shares at $18.00 ($827K) on 2015-03-20, disclosed to the SEC on 2015-03-23.
Scheduled sale ($827k) by EVP & President, Med Surg under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.77 | 11,085 | $197K | 23.8% |
| 2 | $18.00 | 35,000 | $630K | 76.2% |
| Total | $17.94 avg | 46,085 | $827K | 100% |
| Filing → |
| BSX | SELL | 2017-10-30 | $441K | — | Filing → |
| BSX | SELL | 2017-10-02 | $445K | — | Filing → |
| BSX | SELL | 2017-08-30 | $416K | — | Filing → |